<DOC>
	<DOCNO>NCT00784186</DOCNO>
	<brief_summary>The primary goal study determine clinical advantage pre-treatment mifepristone second trimester misoprostol induction abortion . This randomized control double-blinded trial 260 woman compare misoprostol alone mifepristone plus misoprostol second trimester ( 14-21 week ' LMP ) medical abortion .</brief_summary>
	<brief_title>Mifepristone Misoprostol Versus Misoprostol Alone Mid-trimester Termination Pregnancy ( 14 - 21 Weeks LMP ) : A Randomized-controlled Double-blinded Trial</brief_title>
	<detailed_description />
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>14 21 week gestation , base menstrual history clinical exam ( without ultrasound ) Meet legal criterion obtain abortion Present close cervical os vaginal bleeding Live fetus time presentation service Have contraindication study procedure , accord provider Be able consent procedure , either read consent document consent document read Be willing follow study procedure Known previous transmural uterine incision Known allergy mifepristone misoprostol/prostaglandin contraindication use mifepristone misoprostol Any contraindication vaginal delivery , include placenta previa Presentation active labor ( defined moderate severe contraction every 10 minute less )</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Pregnancy termination</keyword>
	<keyword>abortion</keyword>
	<keyword>medical abortion</keyword>
	<keyword>2nd trimester</keyword>
	<keyword>mifepristone</keyword>
	<keyword>misoprostol</keyword>
</DOC>